イスラエルで最高の大腸内視鏡検査医師 - トップ17名の医師

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

ロン・ユリア博士は、胃腸の病気の診断と治療で20年以上の経験があります。彼女は、膵臓炎、嚢胞形成、腸憩室炎などの病状を扱い、過体重の治療も提供しています。彼女の研究活動には、85件の発表された科学論文が含まれています。

学歴

• カザフスタン、アルマトイの医科大学を卒業
• テルアビブのファーストメディカルセンターにてレジデンシーと高度専門化を完了

提供する手術

• クローン病の治療
• 腸憩室炎の治療
• 胃潰瘍の治療
• 膵臓の炎症および嚢胞形成の治療
• ビデオカプセル内視鏡手術
• 胃腸がんの治療
• 過体重の治療
• 肝臓の炎症およびジストロフィーの治療

会員資格

• イスラエル消化器病学コミュニティのメンバー

シボレト博士は、50年以上の実践経験を持つイスラエルのトップの消化器病専門医であり、血液学者です。彼はイヒロヴ医療センターのデータによれば、イスラエルの肝臓の専門家として知られています。

専門分野

オレン・シボレト博士の主な専門分野は肝疾患の治療です。彼は、慢性肝炎や自己免疫、遺伝性肝疾患のような重篤な場合でも、肝臓のあらゆる病理の治療と診断を提供しています。

職務経歴

• スルアスキ（イヒロヴ）医療センターの肝臓科の責任者。

学歴

• ヘブライ大学医学部 — 一般医学の学位
• ヘブライ大学ハダッサ医科大学校 — 消化器学の専門。

科学活動

シボレト博士は肝疾患の研究を行っており、60を超える出版物と100の会議要旨の著者です。

組織への所属

• イスラエル消化器病学会
• アメリカ消化器学会
• ヨーロッパ肝臓研究会議
• アメリカ肝疾患学会。

エルウィン・サント医師は、イスラエルのトップ評価の胃腸科医であり、消化管および肝疾患の治療における専門家です。イスラエルで初めて介入超音波を使用し始めた人物です。欧州消化管内視鏡学会の共同創設者。サント医師は、ソウラスキー医療センターの胃腸科を率いています。

専門分野

サント医師は胃および肝疾患の診断と治療の専門家です。彼の豊富な専門知識の中には膵臓疾患の診断があります。

職務経験

• 2010年から — ソウラスキー医療センター（イヒロフ）胃腸科部長
• 2004-2009 — ソウラスキー医療センター（イヒロフ）介入内視鏡ユニットのディレクター
• 1983-1988 — ベイリンソン病院内科ユニットの副所長。

学歴

• ルース・アンド・ブルース・ラパポート医科大学 — 一般医学の学位
• ベイリンソン病院 — 内科専門。

組織のメンバーシップ

• アメリカ胃腸学会
• イスラエル胃腸学会
• 欧州消化器内視鏡学会および栄養学会。

教育

サックラー医学校、テルアビブ大学

専門

2002-2006 - 内科、内科I科、テルアビブ医療センター

2007-2010 - 胃腸病学、胃腸および肝臓疾患研究所、テルアビブ医療センター。

認められた経験

内科および胃腸病学

追加の教育

2007 - ワイツマン研究所、免疫学

2010-2013 - ノースカロライナ大学チャペルヒル校、米国、免疫学、微生物学、炎症性腸疾患。

臨床経験

1998-2002 - 学術予備軍の軍医。

2013年 - 現在 - 胃腸および肝臓疾患研究所の上級医師、テルアビブ医療センター。

2014年 - 現在 - バクテリオ治療クリニックの所長。

2017年から現在まで - 炎症性腸疾患部門の所長。

学術経験

上級講師、内科部門、テルアビブ大学

会議への参加

60を超える会議

プロフェッショナルな出版物

80以上のプロフェッショナルな出版物

労働組合のメンバーシップ

イスラエル医師会

イスラエル胃腸および肝臓病学協会

アメリカ胃腸病学会

ヨーロッパのクローン病および潰瘍性大腸炎組織

特別な興味と活動の分野

炎症性腸疾患

バクテリオセラピー - 糞便細菌を用いた研究と治療

ラファエル・ブルック教授は、イスラエルでトップクラスの消化器内科医の一人であり、40年以上の臨床経験を持っています。

専門

ラファエル・ブルック教授の専門は、食道、胃、小腸および大腸、膵臓、消化器系の癌の急性および慢性疾患の治療です。

ブルック教授は肝臓学の専門家であり、胆管および肝臓の異常、代謝障害のある患者を治療しています。ラファエル・ブルック医師は、B型およびC型肝炎ウイルスの症状を排除するための最新の医療スキームを適用しています。

職歴

• ソウラスキー医療センターの主任消化器内科医
• ウルフソン医療センターの消化器内科医。

学歴

• テルアビブ大学の医学部。

所属団体

• イスラエル医師会
• イスラエル消化器・肝臓病学会
• アメリカ医師会。

アミール医師は、小児の炎症性腸疾患、セリアック病、好酸球性食道炎の管理を専門としています。彼は小児における内視鏡的手技に精通しています。

教育

• テクテル・アビブ大学、サックラー医学部にて医学科卒業、イスラエル。

専門分野

• ダナ・ドウェク小児病院、テルアビブ・ソウラスキー医療センターにて小児科レジデンシー、イスラエル。
• ダナ・ドウェク小児病院、テルアビブ・ソウラスキー医療センターにて小児消化器病学フェローシップ、イスラエル。

学術経験

• ヘブライ大学にて組織学講師（1999-2001年）。
• 2005-2010年まで様々な施設で大学院看護職を対象とするゲスト講師。
• ダナ小児病院の小児病棟でのローテーション中に、学部生の医学学生を指導および講義（2008-2013年）。
• 2012年から現在にかけて、テルアビブ大学にて小児科の大学院医学教育の講師。

所属

• イスラエル臨床小児医学会
• イスラエル小児消化器病学・栄養学会
• イスラエル外来小児科学会
• イスラエル消化器病学会
• ヨーロッパ小児消化器病学・肝臓病学・栄養学会
• ヨーロッパクローン病および大腸炎組織

Dr. Alon Pikarsky, who graduated from Hebrew University School of Medicine in 1987 and specializes in Surgery and Colorectal Surgery, is affiliated with Hadassah Medical Center. Key takeaways about him:

• Languages: English, Hebrew
• Instructor in Surgery since 1995
• Lecturer in Surgery since 1999
• Senior Lecturer in Surgery since 2005
• Director of Medical Students Program in the Department of Surgery since 1997
• Residency Program Director – Department of Surgery since 2000
• Israel Board Certified in General Surgery since 1998
• Member of various surgical associations since 1998

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.